Allergic Rhinitis (AR) is a non-infectious chronic inflammatory disease of nasal mucosa provoking Th17 response. Chlorogenic acid (CGA), one of the most abundant polyphenol compounds in various agricultural products, possess anti-viral, anti-inflammatory, and anti-bacterial properties. However, the effect of CGA on AR is unclear. Thus, our study explored the effect of CGA in modulating AR-related symptoms and immunoreaction especially Th17 response. AR mice were induced by ovalbumin (OVA) administration and further treated with CGA or dexamethasone. The frequencies of rubbing and sneezing of AR mice were recorded. Histopathological of nasal mucosa were conducted by hematoxylin-eosin staining and periodic acid-schiff staining. The serum and nasal mucosa levels of OVA-immunoglobulin (Ig)E, interferon (IFN)-γ, retinoic acid-associated nuclear orphan receptor (ROR)-γt, and interleukin (IL)-17A were measured by enzyme-linked immunosorbent assay, qRT-PCR, or western blot. The ratio of CD4+IL-17+Th17 cells to CD4+T cells in peripheral blood of AR mice was assessed by flow cytometer. CGA diminished the frequencies of rubbing and sneezing of AR mice in a concentration-dependent manner. CGA attenuated histopathological abnormalities and decreased goblet cell number in nasal mucosal of AR mice. CGA decreased the serum levels of OVA-IgE, ROR-γt, and IL-17A, while increasing the serum level of IFN-γ in AR mice. Meanwhile, CGA decreased the ratio of CD4+IL-17+Th17 cells to CD4+T cells in peripheral blood and the mRNA and protein levels of IL-17A and ROR-γt in AR mice. CGA ameliorated AR-related symptoms in mice by regulating Th17 cells, which could be a candidate for the treatment of AR.